Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
10.82
-0.39 (-3.48%)
At close: Sep 14, 2026, 4:00 PM EDT
10.82
0.00 (0.00%)
After-hours: Sep 14, 2026, 4:10 PM EDT
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $761.51 million as of September 14, 2026. Its market cap has decreased by -25.51% in one year.
Market Cap
761.51M
Enterprise Value
715.80M
1-Year Change
-25.51%
Ranking
Category
Stock Price
$10.82
ChartMarket Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $761.51M, an increase of 490.98%. That is a compound annual growth rate of 6.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 761.51M | -33.62% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 806.89M |
| Silence Therapeutics | 783.93M |
| Aclaris Therapeutics | 783.10M |
| Nuvectis Pharma | 781.63M |
| Annexon | 746.94M |
| Monopar Therapeutics | 740.08M |
| 4D Molecular Therapeutics | 727.57M |
| Achieve Life Sciences | 726.49M |